Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03068520 : Can Hybrid PET-MRI Differentiate Between Radiation Effects and Disease Progression?
PhaseN/A
AgesMin: 18 Years Max: 70 Years
Eligibility
Inclusion Criteria:

- Subject with glial brain tumors,

- Subjects with metastatic brain tumors that were treated with stereotactic radiation
(SRS), * Subjects with metastatic brain tumors which were not treated

Exclusion Criteria:

- glial tumor with no histological diagnosis

- non breast of lung metastasis

- non compliance

- unable to lay still during the scanning

- mri non

- renal failure/gadolinium sensitivity

- less than 5 mm metastatic tumors

- bleeding brain tumors

- pregnancy
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03068520      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740